Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Risk”

6,690 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,690 results

Not applicableStudy completedNCT07010224
What this trial is testing

Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors

Who this might be right for
Elastofibroma Dorsi
Ondokuz Mayıs University 102
Large-scale testing (Phase 3)Looking for participantsNCT07393282
What this trial is testing

Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Who this might be right for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals 270
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Not applicableLooking for participantsNCT06872346
What this trial is testing

Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT

Who this might be right for
Cervical Cancer Screening
Massachusetts General Hospital 7,500
Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Not applicableActive Not RecruitingNCT03672331
What this trial is testing

My Personalized Breast Screening

Who this might be right for
Breast Screening
UNICANCER 53,142
Early research (Phase 1)Ended earlyNCT01801046
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+24 more
University of Southern California 10
Not applicableStudy completedNCT01461070
What this trial is testing

Intestine Bacteria and Breast Cancer Risk

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 175
Not applicableStudy completedNCT01935466
What this trial is testing

Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"

Who this might be right for
Bladder Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 6,107
Large-scale testing (Phase 3)Study completedNCT01259856
What this trial is testing

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Who this might be right for
High Risk Polycythemia VeraHigh Risk Essential Thrombocythemia
Ronald Hoffman 168
Testing effectiveness (Phase 2)Study completedNCT00576979
What this trial is testing

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 51
Large-scale testing (Phase 3)Study completedNCT02143388
What this trial is testing

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

Who this might be right for
Local Advanced High Risk Nasopharyngeal Carcinoma
Zhao Chong 180
Not applicableStudy completedNCT00000703
What this trial is testing

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Not Yet RecruitingNCT07077369
What this trial is testing

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 10
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Not applicableNot Yet RecruitingNCT06943794
What this trial is testing

Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial

Who this might be right for
Gastric (Stomach) Cancer
Fudan University 4,824
Not applicableStudy completedNCT00445653
What this trial is testing

Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding

Who this might be right for
Precancerous Condition
Massachusetts General Hospital 170
Not applicableStudy completedNCT00047970
What this trial is testing

The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer

Who this might be right for
Breast Cancer
National Institute of Environmental Health Sciences (NIEHS) 50,884
Not applicableNot Yet RecruitingNCT06473870
What this trial is testing

Understanding Lung Cancer Related Risk Factors and Their Impact

Who this might be right for
Lung Cancer Screening
Biobizkaia Health Research Institute 6,160
Next Page